Open-source AI predicts key peptide traits before costly lab testing

Engineers at the University of Pennsylvania have developed PeptiVerse, an open-source AI platform designed to predict the chemical and biological properties of peptides. This tool aims to streamline drug discovery by allowing researchers to evaluate potential treatments before committing to expensive laboratory synthesis.